Evaluation of the Validity of Endoscopic Transpapillary Gallbladder Drainage for Acute Cholecystitis Based on the Tokyo Guidelines 2018.


Journal

Journal of clinical gastroenterology
ISSN: 1539-2031
Titre abrégé: J Clin Gastroenterol
Pays: United States
ID NLM: 7910017

Informations de publication

Date de publication:
01 Apr 2024
Historique:
received: 05 11 2022
accepted: 18 04 2023
medline: 18 3 2024
pubmed: 24 5 2023
entrez: 24 5 2023
Statut: epublish

Résumé

We evaluated the validity of endoscopic transpapillary gallbladder drainage (ETGBD) as a bridging therapy prior to elective Lap-C for the patients with acute cholecystitis (AC). The Tokyo Guidelines 2018 recommend early laparoscopic cholecystectomy (Lap-C) for patients with AC, however, some patients require the preoperative drainage because of inadequate for early Lap-C du to background and comorbidities. We performed a retrospective cohort analysis using data from our hospital records from 2018-2021. In total, 71 cases of 61 patients with AC underwent ETGBD. The technical success rate was 85.9%. Patients in the failure group had more complicated branching of the cystic duct. The length of time until feeding was started and until WBC levels normalized, and the length of hospital stay were significantly shorter in the success group. The median waiting period for surgery was 39 days in the ETGBD success cases. The median operating time, amount of bleeding, and length of postoperative hospital stay were 134 min, 83.2g, and 4 days, respectively. In patients who underwent Lap-C, the waiting period for surgery and the operating time were similar between the ETGBD success and failure groups. However, the temporary discharge period after drainage and the length of postoperative hospital stay were significantly longer in the patients with ETGBD failure. Our study revealed that ETGBD has equivalent efficacy prior to elective Lap-C despite some challenges that lower its success rate. Preoperativ ETGBD can improve patient quality of life by eliminating the need for a drainage tube.

Sections du résumé

GOALS OBJECTIVE
We evaluated the validity of endoscopic transpapillary gallbladder drainage (ETGBD) as a bridging therapy prior to elective Lap-C for the patients with acute cholecystitis (AC).
BACKGROUND BACKGROUND
The Tokyo Guidelines 2018 recommend early laparoscopic cholecystectomy (Lap-C) for patients with AC, however, some patients require the preoperative drainage because of inadequate for early Lap-C du to background and comorbidities.
STUDY METHODS
We performed a retrospective cohort analysis using data from our hospital records from 2018-2021. In total, 71 cases of 61 patients with AC underwent ETGBD.
RESULTS RESULTS
The technical success rate was 85.9%. Patients in the failure group had more complicated branching of the cystic duct. The length of time until feeding was started and until WBC levels normalized, and the length of hospital stay were significantly shorter in the success group. The median waiting period for surgery was 39 days in the ETGBD success cases. The median operating time, amount of bleeding, and length of postoperative hospital stay were 134 min, 83.2g, and 4 days, respectively. In patients who underwent Lap-C, the waiting period for surgery and the operating time were similar between the ETGBD success and failure groups. However, the temporary discharge period after drainage and the length of postoperative hospital stay were significantly longer in the patients with ETGBD failure.
CONCLUSIONS CONCLUSIONS
Our study revealed that ETGBD has equivalent efficacy prior to elective Lap-C despite some challenges that lower its success rate. Preoperativ ETGBD can improve patient quality of life by eliminating the need for a drainage tube.

Identifiants

pubmed: 37224282
doi: 10.1097/MCG.0000000000001866
pii: 00004836-990000000-00158
pmc: PMC10919268
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

419-425

Informations de copyright

Copyright © 2023 The Author(s). Published by Wolters Kluwer Health, Inc.

Références

Gomi H, Solomkin JS, Schlossberg D, et al. Tokyo Guidelines 2018: antimicrobial therapy for acute cholangitis and cholecystitis. J Hepatobiliary Pancreat Sci. 2018;25:3–16.
Kiviniemi H, Makela JT, Autio R, et al. Percutaneous cholecystostomy in acute cholecystitis in high-risk patients: an analysis of 69 patients. Int Surg. 1998;83:299–302.
Akinci D, Akhan O, Ozmen M, et al. [Outcomes of percutaneous cholecystostomy in patients with high surgical risk]. Tani Girisim Radyol. 2004;10:323–327.
Hultman CS, Herbst CA, McCall JM, et al. The efficacy of percutaneous cholecystostomy in critically ill patients. Am Surg. 1996;62:263–269.
Dimou FM, Adhikari D, Mehta HB, et al. Outcomes in older patients with grade III cholecystitis and cholecystostomy tube placement: a propensity score analysis. J Am Coll Surg. 2017;224:502–511.e501.
Itoi T, Sofuni A, Itokawa F, et al. Endoscopic transpapillary gallbladder drainage in patients with acute cholecystitis in whom percutaneous transhepatic approach is contraindicated or anatomically impossible (with video). Gastrointest Endosc. 2008;68:455–460.
Toyota N, Takada T, Amano H, et al. Endoscopic naso-gallbladder drainage in the treatment of acute cholecystitis: alleviates inflammation and fixes operator’s aim during early laparoscopic cholecystectomy. J Hepatobiliary Pancreat Surg. 2006;13:80–85.
Pannala R, Petersen BT, Gostout CJ, et al. Endoscopic transpapillary gallbladder drainage: 10-year single center experience. Minerva Gastroenterol Dietol. 2008;54:107–113.
Maekawa S, Nomura R, Murase T, et al. Endoscopic gallbladder stenting for acute cholecystitis: a retrospective study of 46 elderly patients aged 65 years or older. BMC Gastroenterol. 2013;13:65.
Maruta A, Iwata K, Iwashita T, et al. Factors affecting technical success of endoscopic transpapillary gallbladder drainage for acute cholecystitis. J Hepatobiliary Pancreat Sci. 2020;27:429–436.
Ogawa O, Yoshikumi H, Maruoka N, et al. Predicting the success of endoscopic transpapillary gallbladder drainage for patients with acute cholecystitis during pretreatment evaluation. Can J Gastroenterol. 2008;22:681–685.
Yane K, Maguchi H, Katanuma A, et al. Feasibility, efficacy, and predictive factors for the technical success of endoscopic nasogallbladder drainage: a prospective study. Gut Liver. 2015;9:239–246.
Jandura DM, Puli SR. Efficacy and safety of endoscopic transpapillary gallbladder drainage in acute cholecystitis: an updated meta-analysis. World J Gastrointest Endosc. 2021;13:345–355.
Kaneta A, Sasada H, Matsumoto T, et al. Efficacy of endoscopic gallbladder drainage in patients with acute cholecystitis. BMC Surg. 2022;22:224.
Itoi T, Coelho-Prabhu N, Baron TH. Endoscopic gallbladder drainage for management of acute cholecystitis. Gastrointest Endosc. 2010;71:1038–1045.
Storm AC, Vargas EJ, Chin JY, et al. Transpapillary gallbladder stent placement for long-term therapy of acute cholecystitis. Gastrointest Endosc. 2021;94:742–748.e741.
Akhan O, Akinci D, Ozmen MN. Percutaneous cholecystostomy. Eur J Radiol. 2002;43:229–236.
Beland MD, Patel L, Ahn SH, et al. Image-guided cholecystostomy tube placement: short- and long-term outcomes of transhepatic versus transperitoneal placement. AJR Am J Roentgenol. 2019;212:201–204.
Yun SS, Hwang DW, Kim SW, et al. Better treatment strategies for patients with acute cholecystitis and American Society of Anesthesiologists classification 3 or greater. Yonsei Med J. 2010;51:540–545.
Inoue T, Suzuki Y, Yoshida M, et al. Long-term impact of endoscopic gallbladder stenting for calculous cholecystitis in poor surgical candidates: a multi-center comparative study. Dig Dis Sci. 2023;68:1529–1538.
Abe K, Suzuki K, Yahagi M, et al. The efficacy of PTGBD for acute cholecystitis based on the Tokyo Guidelines 2018. World J Surg. 2019;43:2789–2796.

Auteurs

Keiichi Suzuki (K)

Department of Surgery, National Hospital Organization, Tochigi Medical Center.

Hirofumi Naito (H)

Department of Gastroenterology, National Hospital Organization, Tochigi Medical Center, Tochigi, Japan.

Eri Naito (E)

Department of Gastroenterology, National Hospital Organization, Tochigi Medical Center, Tochigi, Japan.

Taketo Sasaki (T)

Department of Surgery, National Hospital Organization, Tochigi Medical Center.

Yusuke Yoshikawa (Y)

Department of Surgery, National Hospital Organization, Tochigi Medical Center.

Kenshi Omagari (K)

Department of Surgery, National Hospital Organization, Tochigi Medical Center.

Naoto Yoshitake (N)

Department of Gastroenterology, National Hospital Organization, Tochigi Medical Center, Tochigi, Japan.

Takero Koike (T)

Department of Gastroenterology, National Hospital Organization, Tochigi Medical Center, Tochigi, Japan.

Takeo Hashimoto (T)

Department of Surgery, National Hospital Organization, Tochigi Medical Center.

Akihiko Tamura (A)

Department of Surgery, National Hospital Organization, Tochigi Medical Center.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH